换一批
换一批A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer.
第一单位：
Department of Surgery, Division of Surgical Oncology, Human Immune Therapy Center, University of Virginia, Charlottesville, VA 22908, USA. kb9d@virginia.edu
作者：
主题词
抗原, 肿瘤(Antigens, Neoplasm);癌症疫苗(Cancer Vaccines);DNA解旋酶类(DNA Helicases);DNA结合蛋白质类(DNA-Binding Proteins);剂量效应关系, 免疫(Dose-Response Relationship, Immunologic);女(雌)性(Female);人类(Humans);免疫显性表位(Immunodominant Epitopes);干扰素γ(Interferon-gamma);甘露醇(Mannitol);黑素瘤特异性抗原(Melanoma-Specific Antigens);肿瘤蛋白质类(Neoplasm Proteins);肿瘤分期(Neoplasm Staging);肿瘤, 腺和上皮(Neoplasms, Glandular and Epithelial);油酸类(Oleic Acids);卵巢肿瘤(Ovarian Neoplasms);肽碎片(Peptide Fragments);腹膜肿瘤(Peritoneal Neoplasms);RNA结合蛋白质类(RNA-Binding Proteins);T淋巴细胞(T-Lymphocytes);治疗结果(Treatment Outcome);接种(Vaccination);疫苗, 亚单位(Vaccines, Subunit)
DOI
10.1097/CJI.0b013e31816dad10
PMID
18391753
发布时间
2020-12-26
- 浏览33
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
